209 related articles for article (PubMed ID: 23564440)
1. Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.
Pearton M; Pirri D; Kang SM; Compans RW; Birchall JC
Adv Healthc Mater; 2013 Oct; 2(10):1401-10. PubMed ID: 23564440
[TBL] [Abstract][Full Text] [Related]
2. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice.
Song JM; Kim YC; Lipatov AS; Pearton M; Davis CT; Yoo DG; Park KM; Chen LM; Quan FS; Birchall JC; Donis RO; Prausnitz MR; Compans RW; Kang SM
Clin Vaccine Immunol; 2010 Sep; 17(9):1381-9. PubMed ID: 20631330
[TBL] [Abstract][Full Text] [Related]
3. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch.
Quan FS; Kim YC; Song JM; Hwang HS; Compans RW; Prausnitz MR; Kang SM
Clin Vaccine Immunol; 2013 Sep; 20(9):1433-9. PubMed ID: 23863506
[TBL] [Abstract][Full Text] [Related]
4. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles.
Song JM; Kim YC; Barlow PG; Hossain MJ; Park KM; Donis RO; Prausnitz MR; Compans RW; Kang SM
Antiviral Res; 2010 Nov; 88(2):244-7. PubMed ID: 20851715
[TBL] [Abstract][Full Text] [Related]
5. Microneedle-based vaccines.
Prausnitz MR; Mikszta JA; Cormier M; Andrianov AK
Curr Top Microbiol Immunol; 2009; 333():369-93. PubMed ID: 19768415
[TBL] [Abstract][Full Text] [Related]
6. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection.
Kim MC; Lee JW; Choi HJ; Lee YN; Hwang HS; Lee J; Kim C; Lee JS; Montemagno C; Prausnitz MR; Kang SM
J Control Release; 2015 Jul; 210():208-16. PubMed ID: 26003039
[TBL] [Abstract][Full Text] [Related]
7. Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.
Pearton M; Kang SM; Song JM; Kim YC; Quan FS; Anstey A; Ivory M; Prausnitz MR; Compans RW; Birchall JC
Vaccine; 2010 Aug; 28(37):6104-13. PubMed ID: 20685601
[TBL] [Abstract][Full Text] [Related]
8. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles.
Quan FS; Kim YC; Compans RW; Prausnitz MR; Kang SM
J Control Release; 2010 Nov; 147(3):326-32. PubMed ID: 20692307
[TBL] [Abstract][Full Text] [Related]
9. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization.
Quan FS; Kim YC; Vunnava A; Yoo DG; Song JM; Prausnitz MR; Compans RW; Kang SM
J Virol; 2010 Aug; 84(15):7760-9. PubMed ID: 20484519
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Immune Responses Conferring Cross-Protection by Skin Vaccination With a Tri-Component Influenza Vaccine Using a Microneedle Patch.
Zhu W; Li S; Wang C; Yu G; Prausnitz MR; Wang BZ
Front Immunol; 2018; 9():1705. PubMed ID: 30105019
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.
Quan FS; Kim YC; Yoo DG; Compans RW; Prausnitz MR; Kang SM
PLoS One; 2009 Sep; 4(9):e7152. PubMed ID: 19779615
[TBL] [Abstract][Full Text] [Related]
12. Local response to microneedle-based influenza immunization in the skin.
del Pilar Martin M; Weldon WC; Zarnitsyn VG; Koutsonanos DG; Akbari H; Skountzou I; Jacob J; Prausnitz MR; Compans RW
mBio; 2012; 3(2):e00012-12. PubMed ID: 22396479
[TBL] [Abstract][Full Text] [Related]
13. Formulation of microneedles coated with influenza virus-like particle vaccine.
Kim YC; Quan FS; Compans RW; Kang SM; Prausnitz MR
AAPS PharmSciTech; 2010 Sep; 11(3):1193-201. PubMed ID: 20676947
[TBL] [Abstract][Full Text] [Related]
14. Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.
Pearton M; Kang SM; Song JM; Anstey AV; Ivory M; Compans RW; Birchall JC
PLoS One; 2010 Aug; 5(8):e12410. PubMed ID: 20811642
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant.
Beljanski V; Chiang C; Kirchenbaum GA; Olagnier D; Bloom CE; Wong T; Haddad EK; Trautmann L; Ross TM; Hiscott J
J Virol; 2015 Oct; 89(20):10612-24. PubMed ID: 26269188
[TBL] [Abstract][Full Text] [Related]
16. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.
Weldon WC; Martin MP; Zarnitsyn V; Wang B; Koutsonanos D; Skountzou I; Prausnitz MR; Compans RW
Clin Vaccine Immunol; 2011 Apr; 18(4):647-54. PubMed ID: 21288996
[TBL] [Abstract][Full Text] [Related]
17. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination.
Chen YH; Lai KY; Chiu YH; Wu YW; Shiau AL; Chen MC
Acta Biomater; 2019 Oct; 97():230-238. PubMed ID: 31362139
[TBL] [Abstract][Full Text] [Related]
18. A Single Intramuscular Dose of a Plant-Made Virus-Like Particle Vaccine Elicits a Balanced Humoral and Cellular Response and Protects Young and Aged Mice from Influenza H1N1 Virus Challenge despite a Modest/Absent Humoral Response.
Hodgins B; Yam KK; Winter K; Pillet S; Landry N; Ward BJ
Clin Vaccine Immunol; 2017 Dec; 24(12):. PubMed ID: 29021303
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the innate stimulatory capacity of plant-derived virus-like particles bearing influenza hemagglutinin.
Won SY; Hunt K; Guak H; Hasaj B; Charland N; Landry N; Ward BJ; Krawczyk CM
Vaccine; 2018 Dec; 36(52):8028-8038. PubMed ID: 30448064
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?
Levin Y; Kochba E; Kenney R
Vaccine; 2014 Jul; 32(34):4249-52. PubMed ID: 24930715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
